ATE380346T1 - Differentialdiagnose von störungen vom eisenmetabolismus - Google Patents

Differentialdiagnose von störungen vom eisenmetabolismus

Info

Publication number
ATE380346T1
ATE380346T1 AT02777081T AT02777081T ATE380346T1 AT E380346 T1 ATE380346 T1 AT E380346T1 AT 02777081 T AT02777081 T AT 02777081T AT 02777081 T AT02777081 T AT 02777081T AT E380346 T1 ATE380346 T1 AT E380346T1
Authority
AT
Austria
Prior art keywords
iron metabolism
differential diagnosis
metabolism disorders
disorders
iron
Prior art date
Application number
AT02777081T
Other languages
English (en)
Inventor
Ralf Roeddiger
Paul Lehmann
Lothar Thomas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE380346T1 publication Critical patent/ATE380346T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/90—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving iron binding capacity of blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Coating With Molten Metal (AREA)
  • Control Of Steam Boilers And Waste-Gas Boilers (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating And Analyzing Materials By Characteristic Methods (AREA)
  • Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
AT02777081T 2001-09-14 2002-09-12 Differentialdiagnose von störungen vom eisenmetabolismus ATE380346T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32252601P 2001-09-14 2001-09-14

Publications (1)

Publication Number Publication Date
ATE380346T1 true ATE380346T1 (de) 2007-12-15

Family

ID=23255267

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02777081T ATE380346T1 (de) 2001-09-14 2002-09-12 Differentialdiagnose von störungen vom eisenmetabolismus

Country Status (8)

Country Link
US (1) US7601684B2 (de)
EP (1) EP1425589B1 (de)
JP (1) JP2005503559A (de)
AT (1) ATE380346T1 (de)
CA (1) CA2459972A1 (de)
DE (1) DE60223931T2 (de)
ES (2) ES2399110T3 (de)
WO (1) WO2003025583A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7459435B2 (en) * 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) * 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
DE10349124A1 (de) 2003-10-22 2005-05-19 Roche Diagnostics Gmbh Differenzialdiagnostik mit Hepcidin
PL1696947T3 (pl) 2003-12-19 2014-08-29 Hoffmann La Roche Zastosowanie erytropoetyny w leczeniu zaburzeń dystrybucji żelaza w przewlekłych chorobach zapalnych jelit
EP1824506A2 (de) * 2004-12-08 2007-08-29 Novartis AG Verwendung von organischen verbindungen
US7586589B2 (en) * 2005-09-24 2009-09-08 Beckman Coulter, Inc. Methods of determination of responsiveness to erythropoietin treatment
JP4925364B2 (ja) * 2006-01-20 2012-04-25 ベックマン コールター, インコーポレイテッド 鉄欠乏を検出する方法
JP4949898B2 (ja) * 2007-03-09 2012-06-13 シスメックス株式会社 血球分析装置
WO2011057744A1 (en) 2009-11-13 2011-05-19 Roche Diagnostics Gmbh Differential diagnosis of iron deficiencies based on hepcidin and mean hemoglobin content per reticulocyte
JP5868982B2 (ja) 2010-09-16 2016-02-24 ザ ジェネラル ホスピタル コーポレイション 診断のための赤血球動力学
US10955423B2 (en) 2015-12-15 2021-03-23 The General Hospital Corporation Methods of estimating blood glucose and related systems
GB201604806D0 (en) * 2016-03-22 2016-05-04 Singapore Volition Pte Ltd Method of identifying a cancer of unknown origin
US11293852B2 (en) 2016-04-07 2022-04-05 The General Hospital Corporation White blood cell population dynamics
EP4103595A4 (de) * 2020-02-11 2024-06-26 Quest Diagnostics Investments LLC System zur bestimmung einer zugrundeliegenden ursache von anämie
JPWO2022102734A1 (de) * 2020-11-13 2022-05-19

Also Published As

Publication number Publication date
WO2003025583A2 (en) 2003-03-27
EP1425589A2 (de) 2004-06-09
DE60223931T2 (de) 2008-04-03
DE60223931D1 (de) 2008-01-17
ES2399110T3 (es) 2013-03-25
US20030073635A1 (en) 2003-04-17
US7601684B2 (en) 2009-10-13
WO2003025583A3 (en) 2003-12-18
JP2005503559A (ja) 2005-02-03
EP1425589B1 (de) 2007-12-05
CA2459972A1 (en) 2003-03-27
ES2297011T3 (es) 2008-05-01

Similar Documents

Publication Publication Date Title
DE60223931D1 (de) Differentialdiagnose von störungen vom eisenmetabolismus
DE602004022793D1 (de) Vorrichtungen zum auffangen von interessierenden analyten in tränen
ATE427114T1 (de) Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomíostase stírungen
WO2005037203A3 (en) Methods and reagents for the treatment of immunoinflammatory disorders
EP1883349A4 (de) Verfahren und gerät zur diagnose von atemwegserkrankungen und zur bestimmung des exacerbationsgrades
EP1781303A4 (de) Verfahren und reagentien zur behandlung von stoffwechselerkrankungen
EP1409544A4 (de) Humane dr4-antikörper und deren anwendungen
SG146653A1 (en) Methods and reagents for the treatment of immunoinflammatory disorders
ATE442592T1 (de) Detektion und/oder beobachtung von synuclein- assoziierten krankheiten
CY1115059T1 (el) Θεραπευτικα απταμερη χρησιμα στην θεραπευτικη αγωγη διαταραχων σχετιζομενων με συμπληρωμα
CY1115860T1 (el) Χρηση hif αλφα σταθεροποιητων για ενισχυση της ερυθροποιησης
GB0117326D0 (en) Napthoquinone-type inhibitors of protein aggregation
MA30384B1 (fr) Therapies combinatoires
BR0313792A (pt) Utilização de proteìna de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento
DK1436427T3 (da) Fremgangsmåde og sammensætning til at vurdere antistofbehandlingsrespons
EP1948280A4 (de) Biliäre/pankreatisches shunt-vorrichtung und verfahren zur behandlung von metabolischen und anderen erkrankungen
ATE376428T1 (de) Metallkomplexverbindungen
IL188036A0 (en) Methods and apparatus for improving the sensitivity of capillary zone electrophoresis
EP1539251A4 (de) Zusammensetzungen und verfahren zur diagnose und therapie von medizinischen erkrankungen mit angiogenese
EP1774029A4 (de) Verfahren zum nachweis des risikos und zur behandlung von typ-2-diabetes
EP1848672A4 (de) Bibliotheken und verfahren zur isolierung von antikörpern
EP1593067A4 (de) Verfahren und vorrichtung zum erwerb über einen verkaufsort
DE602008004556D1 (de) Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin
EP1896042A4 (de) Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen
EP1865778A4 (de) Verfahren zur vermeidung von ödem bei der behandlung von stoffwechselstörungen, entzündlichen erkrankungen und herz-kreislauf-erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1425589

Country of ref document: EP